References
Wells DA, Loken MR (2012) Response to “Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome”. Ann Hematol. doi:10.1007/s00277-012-1504-4
Parmentier S, Meinel J, Oelschlaegel U, Mohr B, Ehninger G, Schaich M, Platzbecker U (2012) Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome. Ann Hematol. doi:10.1007/s00277-012-1488-0
Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, Deeg HJ (2003) Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 102:394–403
van de Loosdrecht AA, Alhan C, Bene MC, Della Porta MG, Dräger AM, Feuillard J, Font P, Germing U, Haase D, Homburg CH, Ireland R, Jansen JH, Kern W, Malcovati L, te Marvelde JG, Mufti GJ, Ogata K, Orfao A, Ossenkoppele GJ, Porwit A, Preijers FW, Richards SJ, Schuurhuis GJ, Subirá D, Valent P, van der Velden VHJ, Vyas P, Westra AH, de Witte TM, Wells DA, Loken MR, Westers TM (2009) Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica 94:1124–1134
van de Loosdrecht AA, Westers TM, Westra AH, Dräger AM, van der Velden VHJ, Ossenkoppele GJ (2008) Identification of distinct prognostic subgroups in low- and intermediate-1-risk MDS by flow cytometry. Blood 111:1067–1077
Ogata K, Della Porta MG, Malcovati L, Picone C, Yokose N, Matsuda A, Yanasjita T, Tamura H, Tsukada J, Dan K (2009) Diagnostic utility of flow cytometry in myelodysplastic syndromes: a prospective validation study in low-risk patients with normal karyotype. Haematologica 94:1066–1074
Della Porta MG, Picone C, Pascutto C, Malcovati L, Tamura H, Handa H, Czader M, Freeman S, Vyas P, Porwit A, Saft L, Westers TM, Alhan C, Cali C, Van de Loosdrecht AA, Ogata K (2012) Multicentre validation of a reproducible flow cytometric score for the diagnosis of low-risk myelodysplastic syndromes: results of a European LeukemiaNET study. Haematologica. doi:10.3324/haematol.2011.048421
Chu S-C, Wanga T-F, Li C-C, Kao R-H, Li D-K, Suc Y-C, Wells DA, Loken MR (2011) Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes. Leuk Res 35:868–873
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oelschlaegel, U., Parmentier, S. & Platzbecker, U. Comment to the response to “Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome”. Ann Hematol 92, 575–576 (2013). https://doi.org/10.1007/s00277-012-1570-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-012-1570-7